AMYLIN PHARMACEUTICALS INC 4
4 · AMYLIN PHARMACEUTICALS INC · Filed Jun 2, 2006
Insider Transaction Report
Form 4
EBERHARD CRAIG A
VP Sales
Transactions
- Exercise/Conversion
Common Stock
2006-06-01$18.85/sh+1,500$28,275→ 23,293 total - Sale
Common Stock
2006-06-01$45.59/sh−1,500$68,385→ 21,793 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2006-06-01−1,500→ 17,800 totalExercise: $18.85From: 2003-05-12Exp: 2013-05-12→ Common Stock (1,500 underlying) - Sale
Common Stock
2006-06-01$46.64/sh−500$23,320→ 21,793 total - Exercise/Conversion
Common Stock
2006-06-01$18.85/sh+500$9,425→ 22,293 total - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
2006-06-01−500→ 17,300 totalExercise: $18.85From: 2003-05-12Exp: 2013-05-12→ Common Stock (500 underlying)
Footnotes (1)
- [F1]This sale was affected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.